BackgroundCheck.run
Search For

Lixin Xin Zhang, 4715310 Sienna Oak Dr, Cypress, TX 77433

Known as:
Lixin X Zhang Lixin Z Zhang Li X Zhang Fuck Lee
Related to:
Junqiang Q Huang 49

Lixin Zhang Phones & Addresses

15310 Sienna Oak Dr, Cypress, TX 77433    832-8125955   

9506 Sandstone St, Houston, TX 77036   

Katy, TX   

Stafford, TX   

Education

Degree: Associate degree or higher
Get Report
Control this profile

Mentions for Lixin Xin Zhang

Career records & work history

Medicine Doctors

Lixin Zhang

Specialties:
Neurology
Work:
Dent Neurological Institute
3980 Sheridan Dr, Buffalo, NY 14226
716-2502000 (phone) 716-2502045 (fax)
Site
Education:
Medical School
Weifang Med Coll, Weifang City, Shandong, China
Graduated: 1987
Procedures:
Continuous EKG, Hearing Evaluation, Inner Ear Tests, Lumbar Puncture, Neurological Testing, Sleep and EEG Testing
Conditions:
Bell's Palsy, Dementia, Ischemic Stroke, Migraine Headache, Obstructive Sleep Apnea, Restless Leg Syndrome, Tension Headache, Transient Cerebral Ischemia, Alcohol Dependence, Alzheimer's Disease, Anemia, Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Atrial Fibrillation and Atrial Flutter, Attention Deficit Disorder (ADD), Autism, Benign Paroxysmal Positional Vertigo, Bipolar Disorder, Bronchial Asthma, Calculus of the Urinary System, Cardiac Arrhythmia, Cardiomyopathy, Carpel Tunnel Syndrome, Chronic Fatigue Syndrome, Chronic Renal Disease, Cirrhosis, Congenital Anomalies of the Heart, Depressive Disorders, Dermatitis, Diabetes Mellitus (DM), Diabetic Peripheral Neuropathy, Disorders of Lipoid Metabolism, Epilepsy, Fractures, Dislocations, Derangement, and Sprains, Hearing Loss, Heart Failure, Hemorrhagic stroke, Herpes Zoster, HIV Infection, Hypertension (HTN), Hypothyroidism, Infectious Liver Disease, Insomnia, Intervertebral Disc Degeneration, Intracranial Injury, Irritable Bowel Syndrome (IBS), Ischemic Heart Disease, Lyme Disease, Malignant Neoplasm of Female Breast, Meningitis, Mitral Valvular Disease, Multiple Sclerosis (MS), Myasthenia Gravis (MG), Obsessive-Compulsive Disorder (OCD), Osteoporosis, Overweight and Obesity, Parkinson's Disease, Peripheral Nerve Disorders, Pneumonia, Poisoning by Drugs, Meds, or Biological Substances, Post Traumatic Stress Disorder (PTSD), Prostatitis, Raynaud's Disease, Rheumatoid Arthritis, Sarcoidosis, Schizophrenia, Spinal Stenosis, Substance Abuse and/or Dependency, Systemic Lupus Erythematosus, Tempromandibular Joint Disorders (TMJ), Urinary Incontinence, Venous Embolism and Thrombosis, Viral Meningitis, Vitamin D Deficiency
Languages:
English
Description:
Dr. Zhang graduated from the Weifang Med Coll, Weifang City, Shandong, China in 1987. He works in Amherst, NY and specializes in Neurology. Dr. Zhang is affiliated with Millard Fillmore Suburban Hospital.
Lixin Zhang Photo 1

Lixin Zhang

Lixin Zhang resumes & CV records

Resumes

Lixin Zhang Photo 31

Lixin Zhang

Work:
Baylor College of Medicine
Assistant Professor
Lixin Zhang Photo 32

Mechanical Designer

Location:
Houston, TX
Work:
Axon Energy Services
Mechanical Designer
Lixin Zhang Photo 33

Assistant Professor At Baylor College Of Medicine

Location:
Houston, TX
Industry:
Research
Work:
Baylor College of Medicine
Assistant Professor at Baylor College of Medicine
Skills:
Computing
Lixin Zhang Photo 34

Lixin Zhang

Lixin Zhang Photo 35

Lixin Zhang

Skills:
Public Health, Lei
Lixin Zhang Photo 36

Lixin Zhang

Publications & IP owners

Us Patents

Composition Comprising An Adenoviral Expression Vector Comprising A Cd40L Fusion Protein For Generating Immune Responses

US Patent:
8236295, Aug 7, 2012
Filed:
Feb 2, 2012
Appl. No.:
13/364370
Inventors:
Albert B. Deisseroth - Potomac MD, US
Lixin Zhang - Houston TX, US
Assignee:
VAXum, LLC - Manassas VA
International Classification:
A61K 48/00
C12N 15/00
US Classification:
424 932, 424 936, 4241991, 4353201
Abstract:
Provided are adenoviral vectors for generating an immune response to antigen. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal sequence upstream of a tumor antigen upstream of CD40 ligand, which is missing all or substantially all of the transmembrane domain rendering CD40L secretable. Also provided are methods of generating an immune response against cells expressing a tumor antigen by administering an effective amount of the invention vector. Further provided are methods of generating an immune response against cancer expressing a tumor antigen in an individual by administering an effective amount of the invention vector. Still further provided are methods of generating immunity to infection by human papilloma virus (HPV) by administering an effective amount of the invention vector which encodes the E6 or E7 protein of HPV. The immunity generated is long term.

Methods Of Generating Immune Responses With Compositions Comprising An Adenoviral Expression Vector Comprising A Cd40L Fusion Protein

US Patent:
8540979, Sep 24, 2013
Filed:
Jul 16, 2012
Appl. No.:
13/549581
Inventors:
Albert B. Deisseroth - Potomac MD, US
Lixin Zhang - Houston TX, US
Assignee:
VAXum, LLC - Manassas VA
International Classification:
A61K 48/00
C12N 15/00
US Classification:
424 932, 4241991, 4353201, 514 44 R
Abstract:
Provided are adenoviral vectors for generating an immune response to antigen. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal sequence upstream of a tumor antigen upstream of CD40 ligand, which is missing all or substantially all of the transmembrane domain rendering CD40L secretable. Also provided are methods of generating an immune response against cells expressing a tumor antigen by administering an effective amount of the invention vector. Further provided are methods of generating an immune response against cancer expressing a tumor antigen in an individual by administering an effective amount of the invention vector. Still further provided are methods of generating immunity to infection by human papilloma virus (HPV) by administering an effective amount of the invention vector which enocodes the E6 or E7 protein of HPV. The immunity generated is long term.

Spar Hull Belly Strake Design And Installation Method

US Patent:
2010019, Aug 5, 2010
Filed:
Feb 4, 2009
Appl. No.:
12/365811
Inventors:
Michael Y. H. Luo - Bellaire TX, US
Harvey O. Mohr - Katy TX, US
Lixin Zhang - Sugar Land TX, US
Assignee:
TECHNIP FRANCE - Courbevoie
International Classification:
B63B 3/14
B63B 35/44
US Classification:
114285, 114264
Abstract:
A spar hull for a floating vessel can include a hard tank having a belly portion, a fixed strake coupled to the outer surface of the tank and a folding strake coupled to the belly portion of the tank, the folding strake having one or more strake panels and one or more support frames. A method for installing folding belly strakes on a spar hull may include providing a floating spar hull having a hard tank with a belly side, rotating the spar so that the belly side is in a first workable position, coupling at least one folding strake to the belly side of the spar, and coupling the strake in a folded position for transport. The method may include positioning the spar hull offshore in a transport position, upending the spar hull, unfolding the strake, fixing the strake in the unfolded position and installing the spar hull.

Spar Hull Belly Strake Design And Installation Method

US Patent:
2012027, Nov 1, 2012
Filed:
Jan 28, 2010
Appl. No.:
13/147256
Inventors:
Michael Y.H. Luo - Bellaire TX, US
Harvey O. Mohr - Katy TX, US
Vera Mohr - Carmine TX, US
Lixin Zhang - Sugar Land TX, US
Kostas Filoktitis Lambrakos - Houston TX, US
Assignee:
TECHNIP FRANCE - Courbevoie
International Classification:
B63B 35/44
B63B 3/38
US Classification:
114285
Abstract:
A spar hull for a floating vessel can include a hard tank having a belly portion, a fixed strake coupled to the outer surface of the tank and a folding strake coupled to the belly portion of the tank, the folding strake having one or more strake panels and one or more support frames. A method for installing folding belly strakes on a spar hull may include providing a floating spar hull having a hard tank with a belly side, rotating the spar so that the belly side is in a first workable position, coupling at least one folding strake to the belly side of the spar, and coupling the strake in a folded position for transport. The method may include positioning the spar hull offshore in a transport position, upending the spar hull, unfolding the strake, fixing the strake in the unfolded position and installing the spar hull.

Adenoviral Vector Vaccine

US Patent:
2014008, Mar 20, 2014
Filed:
Aug 23, 2013
Appl. No.:
13/974353
Inventors:
Albert B. Deisseroth - Potomac MD, US
Lixin Zhang - Houston TX, US
Assignee:
VAXum, LLC - Manassas VA
International Classification:
C07K 14/705
C07K 14/005
US Classification:
4353201
Abstract:
Provided are adenoviral vectors for generating an immune response to antigen. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal sequence upstream of a tumor antigen upstream of CD40 ligand, which is missing all or substantially all of the transmembrane domain rendering CD40L secretable. Also provided are methods of generating an immune response against cells expressing a tumor antigen by administering an effective amount of the invention vector. Further provided are methods of generating an immune response against cancer expressing a tumor antigen in an individual by administering an effective amount of the invention vector. Still further provided are methods of generating immunity to infection by human papilloma virus (HPV) by administering an effective amount of the invention vector which encodes the E6 or E7 protein of HPV. The immunity generated is long term.

Adenoviral Vector Vaccine

US Patent:
2017006, Mar 9, 2017
Filed:
Sep 13, 2016
Appl. No.:
15/263608
Inventors:
- Warrenton VA, US
Lixin Zhang - Houston TX, US
International Classification:
A61K 39/12
C07K 14/005
C12N 15/86
C07K 14/705
Abstract:
Provided are adenoviral vectors for generating an immune response to antigen. The vectors comprise a transcription unit encoding a secretable polypeptide, the polypeptide comprising a secretory signal sequence upstream of a tumor antigen upstream of CD40 ligand, which is missing all or substantially all of the transmembrane domain rendering CD40L secretable. Also provided are methods of generating an immune response against cells expressing a tumor antigen by administering an effective amount of the invention vector. Further provided are methods of generating an immune response against cancer expressing a tumor antigen in an individual by administering an effective amount of the invention vector. Still further provided are methods of generating immunity to infection by human papilloma virus (HPV) by administering an effective amount of the invention vector which encodes the E6 or E7 protein of HPV. The immunity generated is long term.

Ctc Biomarker Assay To Combat Breast Cancer Brain Metastasis

US Patent:
2014032, Oct 30, 2014
Filed:
Nov 28, 2012
Appl. No.:
14/361248
Inventors:
- Houston TX, US
Lon Ridgway - Houston TX, US
Lixin Zhang - Houston TX, US
Assignee:
BAYLOR COLLEGE OF MEDICINE - Houston TX
International Classification:
C12Q 1/68
G01N 33/574
US Classification:
424649, 435 723, 435 611, 435 612
Abstract:
Embodiments of the present invention concern methods related to treating, prognosticating and/or diagnosing at least brain metastatic breast cancer. Embodiments of the methods include characterizing circulating tumor cells for the presence or absence of EpCAM and, upon identification of EpCAM negative cells and identification of the status of other markers (such as heparanase and/or Notch1, for example), treating the individual based on the determination of the characterization.

Possible Relatives

David Zhang  Dawei Zhang  Dazhi Zhang  De K Zhang  Da Q Zhang  Dachuan Zhang  Daijun Zhang  Lixin Li  Lixin Lin  Lixin X Liu 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.